Cash Flow Surgical Science Sweden AB Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
158.00
268.00
208.00
65.00
19.00
15.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-65.00
-5.00
-65.00
-46.00
-5.00
25.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
137.00
238.00
129.00
39.00
23.00
55.00
Cash Flow from Investing Activities
-47.00
-44.00
-34.00
-2,732.00
-8.00
-210.00
Cash Flow from Financing Activities
227.00
15.00
17.00
2,922.00
4.00
185.00
Net Cash Inflow / Outflow
333.00
200.00
117.00
229.00
17.00
30.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
16.00
-9.00
5.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in SEK Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Surgical Science Sweden AB
Figures in Million
consolidated Cash Flow Results
Change(SEK)
Change(%)
Profit Before Tax
158.093
172.624
-14.00
-8.42%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-65.888
-92.563
27.00
28.82%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
137.225
65.76
72.00
108.68%
Cash Flow from Investing Activities
-47.53
-6.265
-41.00
-658.66%
Cash Flow from Financing Activities
227.653
-4.81
231.00
4832.91%
Net Cash Inflow / Outflow
333.789
59.653
274.00
459.55%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
16.441
4.968
12.00
230.94%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -42.41% vs 84.03% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
137.22
238.29
-42.41%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
